Revitalizing monoamine oxidase inhibitors: a call for action

Even more importantly from a clinical-care point of view, the under-usage of MAOIs has caused much prolonged and needless suffering and avoidable deaths. [...]it is crucial to have these essential drugs available in the clinician’s armamentarium and to have clinicians who are knowledgeable about the...

Full description

Saved in:
Bibliographic Details
Published in:CNS spectrums 2020-08, Vol.25 (4), p.452-454
Main Authors: Gillman, P. Ken, Feinberg, S. Shalom, Fochtmann, Laura J.
Format: Article
Language:English
Subjects:
Antidepressants
Antidepressive Agents - adverse effects
Antidepressive Agents - therapeutic use
Best practice
Clinical medicine
Clinical practice guidelines
Continuing education
Depressive Disorder - drug therapy
Drug interactions
Education
Electroconvulsive therapy
Expert Testimony
Humans
Lifesaving
Monoamine Oxidase Inhibitors - adverse effects
Monoamine Oxidase Inhibitors - therapeutic use
Patients
Physicians
Practice Guidelines as Topic
Psychiatrists
Societies, Medical
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Even more importantly from a clinical-care point of view, the under-usage of MAOIs has caused much prolonged and needless suffering and avoidable deaths. [...]it is crucial to have these essential drugs available in the clinician’s armamentarium and to have clinicians who are knowledgeable about their usage. [...]psychiatrists overestimate the risks of side effects, drug–drug interactions, and the difficulty of following a low-tyramine diet with MAOIs.8,9 It has been pointed out that there is much misleading and incorrect information contained in standard texts, including the United States Physicians’ Desk Reference (PDR), the European electronic Medicines Compendium (eMC), and the British National Formulary (BNF); these texts require urgent updating to remove errors and bring them into line with state-of-the-art knowledge. Improvements in education and clinical practice guidelines, in combination with advocacy efforts to assure continued availability of MAOIs worldwide, will help patients continue to reap the benefits of these life-saving medications.
ISSN:1092-8529
2165-6509
DOI:10.1017/S1092852919001196